Printer Friendly

SPECTRASCIENCE GETS TOTAL OF $3,252,998 FROM WARRANT EXERCISE

 MINNEAPOLIS, Feb. 18 /PRNewswire/ -- SpectraScience, Inc., (NASDAQ: SPSC) announced today that it has received approximately $2,050,000 in new funds as a result of the exercise of common stock purchase warrants since the warrants were extended on Feb. 3, 1993. Together with amounts received before the extension, the proceeds of the warrant exercise totaled $3,252,998 upon purchase of 4,337,331 shares at the exercise price of 75 cents per share.
 The warrants were originally issued in connection with a $4 million equity financing in February 1992. Daryl F. Yurek, chairman and chief executive officer, said approximately 65 percent of the warrants issued in the 1992 financing were exercised. The remaining warrants expired at the close of business yesterday, except for 250,000 warrants held by a consultant to the company which were extended until May 3, 1993. A total of 25,000 restricted shares of common stock were also issued to the consultant as compensation for its services.
 "We are pleased to have successfully concluded this financing," Yurek said. "The new funds should enable us to complete development and begin production of our diagnostic system for coronary artery disease, which the company expects to bring to market later this year."
 SpectraScience designs, develops, manufactures and markets laser- enhanced systems for the diagnosis of cardiovascular disease. The company's diagnostic system uses laser-induced fluoroscopy to identify and characterize coronary artery disease.
 -0- 2/18/93
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen Inc., 612-371-0000 or Tom Ahmann of SpectraScience, Inc., 612-559-4000/
 (SPSC)


CO: SpectraScience, Inc. ST: Minnesota IN: MTC SU:

DS -- MN008 -- 7903 02/18/93 12:36 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1993
Words:271
Previous Article:POTASH CORPORATION OF SASKATCHEWAN INC. 1992 NET INCOME INCREASED 29 PERCENT
Next Article:DAIN BOSWORTH'S VAIL CONFERENCE FEATURES AN EXPANDED ROSTER OF SMALL-CAP, HIGH GROWTH COMPANIES
Topics:


Related Articles
SPECTRASCIENCE REPORTS THIRD QUARTER RESULTS
SPECTRASCIENCE LASER DIAGNOSTIC SYSTEM USED IN SUCCESSFUL CORONARY PROCEDURE AT CLEVELAND CLINIC
SPECTRASCIENCE GETS $1.1 MILLION FROM WARRANT EXERCISE
SPECTRASCIENCE REPORTS LOSS FOR 1992
SPECTRASCIENCE REPORTS FIRST QUARTER RESULTS, CLINICAL PROGRESS
SPECTRASCIENCE ELECTS McMAHON PRESIDENT AND CHIEF EXECUTIVE OFFICER
SPECTRASCIENCE REPORTS REDUCED LOSS FOR THIRD QUARTER
SPECTRASCIENCE FILES 510K WITH FOOD AND DRUG ADMINISTRATION
SPECTRASCIENCE REPORTS REDUCED LOSS FOR FOURTH QUARTER AND 1993 YEAR
SpectraScience Commences Shareholder's Rights Offering.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters